Summary
Chlamydia pneumoniae is an obligate intracellular pathogen responsible for respiratory diseases, including pneumonia and bronchitis, and is highly involved in chronic diseases, including atherosclerosis, asthma, and Alzheimer's disease. We previously showed that the host apoptotic factor caspase-9 played a crucial role for chlamydial multiplication and host apoptosis inhibition by chlamydial infection. To identify chlamydial genes interacting with human caspase-9, yeast two-hybrid screening was performed and 5 chlamydial genes, including Cpj0838 and pmpG were isolated from the C. pneumoniae genomic library. Pull-down experiments showed that caspase-9 physically bound to the Cpj0838 product and chlamydial cells, which contain PmpG proteins. This study could provide a clue to understanding host-Chlamydia interactions, especially the apoptosis repression by Chlamydia infection.
Main text
Chlamydia pneumoniae is an obligate intracellular bacterium firstly described as a pathogen causing acute respiratory diseases (Grayston et al., 1986) . C. pneumoniae was isolated from chronic bronchitis patients (Blasi et al., 1998) , and may be also involved in other chronic inflammatory processes, such as atherosclerosis (Rosenfeld et al., 2000) , asthma (Hahn et al., 1991) , and Alzheimer's disease (Balin et al., 1998) . Chlamydia species show different morphologies and functions in intra-and extra-cellular environments, referred to as a biphasic developmental cycle, i.e., the infectious but metabolically inert elementary body (EB), and the metabolically active but non-infectious reticulate body (RB) (Moulder, 1991) . EBs invade into host cells by inducing phagocytosis and differentiate into RBs within inclusions derived from phagosomes. RBs multiply by binary fission with nutrients acquired from the host cell. At the end of the developmental cycle, the RB converts into an EB and the EB is released from the host cell, ready for subsequent infection. In addition, during persistent infection caused by the exposure to interferon-gamma (IFN-γ) or antibiotics, RBs differentiate into aberrantly large and non-multiplying RBs (Belland et al., 2003a) .
Apoptosis is a crucial process for the maintenance of homeostasis in multicellular organisms. When mitochondrion-dependent apoptosis is activated by internal stresses such as exposure to staurosporine (STS) and tumor necrosis factor alpha (TNF-α), anti-apoptotic Bcl-2 family proteins, including Bcl-2 and Mcl-1, are inactivated, and pro-apoptotic Bcl-2 family proteins, including Bax, Bid, and Bak, are activated (Tafani et al., 2002) . Subsequently, cytochrome c is released from mitochondria into the cytoplasm and triggers the activation of caspase-9 by forming an apoptosome with Apaf-1. Activated caspase-9 in turn activates the effector caspase-3 to promote apoptosis (Chowdhury et al., 2006) . The elimination of pathogen-infected cells is an important outcome of apoptosis as a primary defense mechanism against intracellular bacteria; however, intracellular pathogens have developed a variety of strategies to evade the immune system by the inhibition of host cell apoptosis (Gao and Kwaik, 2000) . C. pneumoniae has been previously reported to inhibit apoptosis induced by STS and TNF-α (Geng et al., 2000; Rahman et al., 2015) .
Investigation carried out to clarify the molecular mechanisms modulating host apoptosis using C. trachomatis has shown that Chlamydia infection prevents cytochrome c release and caspase-3 cleavage (Fan et al., 1998) . This prevention was explained by specific degradation of the pro-apoptotic BH3-only proteins such as Bad by a chlamydial protease/proteasome-like activity factor (CPAF) (Fischer et al., 2004) . However, subsequent studies have shown that the proteolysis of reported CPAF substrates was due to the enzymatic activity in cell lysates rather than in intact cells (Chen et al., 2012) .
Instead of degradation of pro-apoptotic factors, a variety of explanations for chlamydial apoptotic repression have been presented, including mislocalization of pro-apoptotic factors and stabilization of anti-apoptotic factors. For example, it was shown that pro-apoptotic Bad was sequestered to C. trachomatis inclusion via a host factor 14-3-3β and its inclusion protein IncG (Verbeke et al., 2006) , and a pro-apoptotic effector, protein kinase Cδ (PKCδ), was diverted to the inclusion (Tse et al., 2005) . C. trachomatis deubiquitinating enzyme Cdu1 on the inclusion membrane was shown to interact with, and stabilize, anti-apoptotic Mcl-1 by deubiquitination at the chlamydial inclusion for protection agaisnt host defenses (Fischer et al., 2017) . It was shown that infection with C. trachomatis and C. pneumoniae led to up-regulation and stabilization of the cellular inhibitor of apoptosis 2 (cIAP2), resulting in the inhibition of apoptosis (Wahl et al., 2003) . However, C. pneumoniae species contain no genes significantly similar to the C. trachomatis Cdu1 (data not shown), and the 14-3-3β
was not recruited onto the C. pneumoniae inclusion (Verbeke et al., 2006) . Using cells deficient in anti-apoptotic factors such as cIAP2 and Mcl-1, it was shown that the functions of these proteins are not essential for apoptosis-protection by C. trachomatis (Ying et al., 2008) .
In our previous study, we found that during C. pneumoniae infection, caspase-9 was sequestered to, and accumulated into, the inclusion and, interestingly, it was activated even under conditions lacking Apaf-1, and caspase-9 activation supported infection by C. pneumoniae (Rahman et al., 2015) . It is possible that there might be many paths involved in the control of host apoptosis by chlamydial infection and each Chlamydia species evolutionally alter different paths for their tissue or host tropism. In this research, we constructed a whole genome library of C. pneumoniae for yeast two-hybrid (Y2H) screening, and pursued chlamydial genes interaction with caspase-9.
To construct a chlamydial genome library for Y2H screening, DNA fragments coding chlamydial genes were individually amplified by PCR using C. pneumoniae J138 genomic DNA as a template (Miura et al., 2008) (Figs. 1 and 2a) . In addition to the 20-base gene specific sequences, forward and reverse primers contained extra 20-base sequences, 5′-AGGCCGAATTCCCGGGGATC-3′ and 5′-CCGCTGCAGGTCGACGGATC-3′, respectively, for in vivo homologous recombination with pGBKT7 vector at its BamHI site (Clontech/Takara, Mountain View, CA). PCR products and the pGBKT7 vector digested with BamHI were transformed into Saccharomyces cerevisiae AH109 cells (Fukunaga et al., 2013) . Each yeast strain carrying pGBKT7+chlamydial gene was isolated on SD medium without Trp (SD-W). The sizes of the chlamydial genes in the 1072 yeast strains were confirmed by colony PCR using primers, sequences of which were the same as the extra 20-base sequences for in vivo homologous recombination (Fig. 2b) . Thirty-two yeast strains were eliminated from the 1072 clones because of the growth on SD medium without Trp, Ade, and His (SD-WAH) as pseudo-positive clones. Twenty randomly selected strains were subjected to western blotting analysis using an anti-c-Myc mouse monoclonal antibody (Clontech). All samples showed target proteins at expected sizes at detectable levels (Fig. 2c) . Here, the chlamydial genome library for Y2H screening has been established.
To construct a bait vector, pGADT7+caspase-9, a human caspase-9 DNA fragment was amplified by PCR using human aorta cDNA library as a template and two primers, 5′-CATCGATACGGGATCATGGACGAAGCGGATCGGC-3′ and 5′-CGAGCTCGATGGATCGGGGCCCTGGCCTTATGAT-3′. The DNA fragment was cloned into a BamHI site of pGADT7 vector using the infusion cloning method (Clontech). After confirmation of the DNA sequence, pGADT7+caspase-9 was individually transformed into the 1040 yeast strains.
The growth of transformants was tested on an SD medium without Leu, Trp, Ade and His (SD-LWAH). As a result, 8 chlamydial genes were isolated as candidates. After retrieving the plasmids and re-transformation, 5 genes were confirmed as positive by Y2H (Fig. 2d) . The 5 genes are Cpj0444 (pmpG6 coding a polymorphic membrane protein (Pmp) G, homologous to C. trachomatis CT871), Cpj0838 (mnmE/TrmE coding tRNA modification GTPase, CT698), Cpj0056
(pgcA/pgm coding phosphoglucomutase, CT295), Cpj0948 (glgA coding glycogen synthase, CT798), and Cpj0512 (a hypothetical protein, CT425). The 5 gene products do not contain any caspase-9
cleavage sites or domains such as caspase recruitment domains, and their amino acid sequences are not significantly conserved among one another (data not shown).
Each chlamydial genome encodes a variable number of Pmp genes (Azuma et al., 2006) . C.
trachomatis PmpG, the most immunogenic and a major constituent of outer membrane complex (Mygind et al., 2000) , is expressed throughout all stages of the developmental cycle (Belland et al., 2003b) . Cpj0444 is a paralogue of 15 pmpG family genes in the genome of C. pneumoniae J138 (data not shown). To clarify whether caspase-9 can bind to the chlamydial outer membrane, a pull-down experiment was carried out using recombinant caspase-9 and the EBs of C. pneumoniae J138. Human caspase-9 DNA was amplified by PCR using pGADT7+caspase-9 as a template and two primers, 5′-TTTGGATCCCATATGGACGAAGCGGATCGGCG-3′ and 5′-AAAGTCGACGGGGCCCTGGCCTTATGATG-3′. The PCR product was cloned into the BamHI and SalI sites of pGEX(2T-P) after removing the SRP1 gene from pNOY3198 (Azuma et al., 1995) . After confirmation of the DNA sequence of pGEX(2T-P)+caspase-9, glutathione-S-transferase (GST) fused caspase-9 proteins (GST-Casp9) were purified from the transformed E. coli DH5α. Briefly, cells were lysed using the lysis buffer (1% Triton X-100 and 1×
phosphate buffered saline (PBS), pH7.4 (Sigma/Merch, Darmstadt, Germany)) by ultrasonication on ice and the supernatant was collected by centrifugation at 7,740 × g at 4˚C for 15 min. GST-Casp9 was purified using Glutathione Sepharose 4B beads (Amersham/GE Healthcare, Marlborough, MA).
GST-Casp9 and purified EBs of C. pneumoniae J138 (Rahman et al., 2015) were mixed in lysis buffer and incubated at 37˚C for 15 min. EBs were washed with lysis buffer three times and collected by centrifugation at 4˚C for 5 min at 21,500 × g. GST-Casp9 was then analyzed by western blotting using anti-pro-caspase-9 mouse monoclonal antibody (Santa Cruz, Dallas, TX), followed by a second detection using anti-Chlamydia Pmp mouse monoclonal antibody (Cp-11, HITACHI, Tokyo, Japan). In both detections, alkaline phosphatase conjugated anti-mouse IgG goat polyclonal antibody (Santa Cruz) was used as a secondary antibody, and target proteins were visualized using CDP-star (Roche, Basel, Switzerland). The results indicate caspase-9 binding to EBs (Fig. 3a) . This supports the previous observation that caspase-9 accumulates in inclusions (Rahman et al., 2015) , as well as the finding of the Y2H assay. Further investigation is required to clarify the EB factor(s)
involved in the binding of caspase-9 and its significance.
MnmE is well conserved in all three kingdoms of life and is involved in the modification of uridine bases (U34) at the first anticodon position of tRNAs. However, no data exists regarding the localization and functions of chlamydial MnmE. To confirm the interaction between Cpj0838 and caspase-9, a pull-down experiment was performed. To prepare Cpj0838 protein, a Cpj0838 DNA fragment was amplified by PCR using two primers, 5′-CGCGCGGCAGCCATATGCTAAAGCACGATACCATT-3′ and 5′-GGATCCTCGAGCATACTATTTTCCAATGCAAAATTTAC-3′, and cloned into a NdeI site of pET-15b vector (Clontech). After confirmation of the DNA sequence, E. coli BL21(DE3) was transformed with the pET-15b+Cpj0838. Cells were lysed using lysis buffer (50mM NaH 2 PO 4 , 300mM NaCl,10mM imidazole pH 8.0) and His-tagged Cpj0838 (His-Cpj0838) was purified using a Ni-NTA spin column (Qiagen, Venlo, Netherlands). GST-Casp9 and His-Cpj0838 were mixed in the pull-down buffer (1×PBS, 1 mM DTT, 0.5% Triton X-100, and 10 mM MgSO 4 , pH 7.4) at 25˚C for 10 min, and GST-Casp9 was retrieved with glutathione beads. After washing the beads three times with the pull-down buffer, the proteins on the beads were analyzed by western blotting using anti pro-caspase-9 mouse monoclonal antibody (Santa Cruz) and alkaline phosphatase conjugated anti-6X His tag monoclonal antibody (Abcam, Cambridge, UK). The result of the pull-down experiment showed that Cpj0838 bound to caspase-9 (Fig. 3b) . This indicates that Cpj0838/MnmE might function pleiotropically not only for the modification of tRNA but also for C. pneumoniae infection.
C. trachomatis was reported to accumulate glycogen, while Chlamydia psittaci and C. pneumoniae could not (Gilkes et al., 1958; Moulder, 1991) . However, during C. psittaci infection, glycogen production in HeLa cells was increased (Ojcius et al., 1998) , and all chlamydial genomes encode the genes necessary for both glycogen biosynthesis and catabolism (data not shown). It is possible that all chlamydia species can accumulate glycogen within the chlamydial inclusion or host cytoplasm.
Interestingly, C. trachomatis glycogen synthase, GlgA, was shown to be secreted into the host cell cytoplasm (Lu et al., 2013) . The products of Cpj0948/glgA might play an important role, possibly in conjunction with caspase-9. Additionally, the glucose metabolism enzyme, phosphoglucomutase (PgcA), is known to be involved in the production of polysaccharides, including glycogen, and the pathogenicity in bacterial pathogens (Buchanan et al., 2005) . However, interactions among caspase-9, GlgA, and PgcA were shown only by Y2H, it is possible that the product of Cpj0056/pgcA is located in inclusions and caspase-9 is involved in the glycogen metabolism accompanied by two additional enzymes, GlgC (Cpj0607) and GlgB (Cpj0475) (Supplemental Fig. S1 ).
The hypothetical protein encoded by C. trachomatis CT425, which is homologous to Cpj0512, was shown to be immunogenic in humans infected with C. trachomatis (Barker et al., 2008 b) GST-Casp9 and His-Cpj0838 were mixed together and pulled down with glutathione beads.
GST-Casp9 and His-Cpj0838 were detected separately. 
